Document Detail


Candida lusitaniae osteomyelitis in a premature infant.
MedLine Citation:
PMID:  8397571     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Candida lusitaniae is emerging as an opportunistic pathogen in premature infants. Treatment of C. lusitaniae is challenging due to frequent resistance of this organism to antifungal agents and lack of standardized susceptibility testing for fungi. We report the case of a premature infant with C. lusitaniae osteomyelitis in whom treatment was successful with 5-fluorocytosine and fluconazole.
Authors:
E M Oleinik; P Della-Latta; M G Rinaldi; L Saiman
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  American journal of perinatology     Volume:  10     ISSN:  0735-1631     ISO Abbreviation:  Am J Perinatol     Publication Date:  1993 Jul 
Date Detail:
Created Date:  1993-11-04     Completed Date:  1993-11-04     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8405212     Medline TA:  Am J Perinatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  313-5     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Columbia University, New York, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Candidiasis / drug therapy,  microbiology*
Diseases in Twins*
Fluconazole / therapeutic use
Flucytosine / therapeutic use
Humans
Infant, Newborn
Infant, Premature, Diseases / drug therapy,  microbiology*
Male
Osteomyelitis / drug therapy,  microbiology*
Chemical
Reg. No./Substance:
2022-85-7/Flucytosine; 86386-73-4/Fluconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Heparin therapy for congenital antithrombin III deficiency in pregnancy.
Next Document:  Anterior spinal artery syndrome mimicking infantile spinal muscular atrophy.